1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Tissue Engineered - Skin Substitutes - Pipeline Review, 2015

Tissue Engineered - Skin Substitutes - Pipeline Review, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 67 pages

Tissue Engineered - Skin Substitutes - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Tissue Engineered - Skin Substitutes - Pipeline Review, 2015" provides an overview of Tissue Engineered - Skin Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Engineered - Skin Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Tissue Engineered - Skin Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Engineered - Skin Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Engineered - Skin Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Tissue Engineered - Skin Substitutes - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Tissue Engineered - Skin Substitutes Overview 5
3 Products under Development 6
3.1 Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development 6
3.2 Tissue Engineered - Skin Substitutes - Pipeline Products by Segment 7
3.3 Tissue Engineered - Skin Substitutes - Pipeline Products by Territory 8
3.4 Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path 9
3.5 Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date 10
4 Tissue Engineered - Skin Substitutes - Pipeline Products under Development by Companies 11
4.1 Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development 11
4.2 Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development 12
5 Tissue Engineered - Skin Substitutes Companies and Product Overview 13
5.1 Adept Medical Limited Company Overview 13
5.1.1 Adept Medical Limited Pipeline Products and Ongoing Clinical Trials Overview 13
5.2 AGAM Biological Products Company Overview 14
5.2.1 AGAM Biological Products Pipeline Products and Ongoing Clinical Trials Overview 14
5.3 Agenta Biotechnologies, Inc. Company Overview 15
5.3.1 Agenta Biotechnologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 15
5.4 Organogenesis, Inc. Company Overview 17
5.4.1 Organogenesis, Inc. Pipeline Products and Ongoing Clinical Trials Overview 17
5.5 Smith and Nephew Plc Company Overview 21
5.5.1 Smith and Nephew Plc Pipeline Products and Ongoing Clinical Trials Overview 21
5.6 Sree Chitra Tirunal Institute for Medical Sciences and Technology Company Overview 24
5.6.1 Sree Chitra Tirunal Institute for Medical Sciences and Technology Pipeline Products and Ongoing Clinical Trials Overview 24
5.7 Stratatech Corporation Company Overview 25
5.7.1 Stratatech Corporation Pipeline Products and Ongoing Clinical Trials Overview 25
5.8 Tel Aviv University Company Overview 37
5.8.1 Tel Aviv University Pipeline Products and Ongoing Clinical Trials Overview 37
5.9 Tissue Regenix Ltd Company Overview 38
5.9.1 Tissue Regenix Ltd Pipeline Products and Ongoing Clinical Trials Overview 38
5.10 Worcester Polytechnic Institute Company Overview 42
5.10.1 Worcester Polytechnic Institute Pipeline Products and Ongoing Clinical Trials Overview 42
6 Tissue Engineered - Skin Substitutes- Recent Developments 43
7 Appendix 64
7.1 Methodology 64
7.2 About GlobalData 66
7.3 Contact Us 67
7.4 Disclaimer 67

1.1 List of Tables
Table 1: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development 6
Table 2: Tissue Engineered - Skin Substitutes - Pipeline Products by Segment 7
Table 3: Tissue Engineered - Skin Substitutes - Pipeline Products by Territory 8
Table 4: Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path 9
Table 5: Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date 10
Table 6: Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development 11
Table 7: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development 12
Table 8: Adept Medical Limited Pipeline Products and Ongoing Clinical Trials Overview 13
Table 9: Plastic Surgery Graft - Product Status 13
Table 10: Plastic Surgery Graft - Product Description 13
Table 11: AGAM Biological Products Pipeline Products and Ongoing Clinical Trials Overview 14
Table 12: Skin Substitute - Product Status 14
Table 13: Skin Substitute - Product Description 14
Table 14: Agenta Biotechnologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 15
Table 15: Implantable Mesh - Tissue Support - Product Status 15
Table 16: Implantable Mesh - Tissue Support - Product Description 15
Table 17: Skin Graft - Post-Burns - Product Status 16
Table 18: Skin Graft - Post-Burns - Product Description 16
Table 19: Organogenesis, Inc. Pipeline Products and Ongoing Clinical Trials Overview 17
Table 20: Dermagraft - Epidermolysis Bullosa - Product Status 18
Table 21: Dermagraft - Epidermolysis Bullosa - Product Description 18
Table 22: Dermagraft - Rotator Cuff Repair - Product Status 19
Table 23: Dermagraft - Rotator Cuff Repair - Product Description 19
Table 24: Dermagraft - Venous Leg Ulcers Repair - Product Status 20
Table 25: Dermagraft - Venous Leg Ulcers Repair - Product Description 20
Table 26: Smith and Nephew Plc Pipeline Products and Ongoing Clinical Trials Overview 21
Table 27: ICX-SKN - Product Status 22
Table 28: ICX-SKN - Product Description 22
Table 29: KERAGRAF - Product Status 23
Table 30: KERAGRAF - Product Description 23
Table 31: Sree Chitra Tirunal Institute for Medical Sciences and Technology Pipeline Products and Ongoing Clinical Trials Overview 24
Table 32: Skin Graft Substitutes - Wound - Product Status 24
Table 33: Skin Graft Substitutes - Wound - Product Description 24
Table 34: Stratatech Corporation Pipeline Products and Ongoing Clinical Trials Overview 25
Table 35: ExpressGraft - Antineoplastic - Product Status 26
Table 36: ExpressGraft - Antineoplastic - Product Description 26
Table 37: ExpressGraft - Sclerotic Digital Ulcers - Product Status 27
Table 38: ExpressGraft - Sclerotic Digital Ulcers - Product Description 27
Table 39: ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Status 28
Table 40: ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Description 28
Table 41: ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Status 29
Table 42: ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Description 29
Table 43: ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Status 30
Table 44: ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Description 30
Table 45: ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Status 31
Table 46: ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Description 31
Table 47: ExpressGraftEnhance Tissue - Product Status 32
Table 48: ExpressGraftEnhance Tissue - Product Description 32
Table 49: StrataGraft - Epidermolysis Bullosa - Product Status 33
Table 50: StrataGraft - Epidermolysis Bullosa - Product Description 33
Table 51: StrataGraft - Scar Revision - Product Status 34
Table 52: StrataGraft - Scar Revision - Product Description 34
Table 53: StrataGraft - Scleroderma Digital Ulcers - Product Status 35
Table 54: StrataGraft - Scleroderma Digital Ulcers - Product Description 35
Table 55: StrataGraft - Severe Burns - Product Status 36
Table 56: StrataGraft - Severe Burns - Product Description 36
Table 57: Tel Aviv University Pipeline Products and Ongoing Clinical Trials Overview 37
Table 58: Artificial Skin Graft - Product Status 37
Table 59: Artificial Skin Graft - Product Description 37
Table 60: Tissue Regenix Ltd Pipeline Products and Ongoing Clinical Trials Overview 38
Table 61: dCELL Dermis Matrix - Acute Wounds - Product Status 39
Table 62: dCELL Dermis Matrix - Acute Wounds - Product Description 39
Table 63: dCELL Human Dermis - Chronic Wounds - Product Status 40
Table 64: dCELL Human Dermis - Chronic Wounds - Product Description 40
Table 65: dCELL Human Dermis - Plastic Surgery - Product Status 41
Table 66: dCELL Human Dermis - Plastic Surgery - Product Description 41
Table 67: Worcester Polytechnic Institute Pipeline Products and Ongoing Clinical Trials Overview 42
Table 68: Extracellular Matrix Scaffold - Product Status 42
Table 69: Extracellular Matrix Scaffold - Product Description 42
Table 70: Glossary 65

1.2 List of Figures
Figure 1: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development 6
Figure 2: Tissue Engineered - Skin Substitutes - Pipeline Products by Segment 7
Figure 3: Tissue Engineered - Skin Substitutes - Pipeline Products by Territory 8
Figure 4: Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path 9
Figure 5: Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date 10

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Advanced Wound Care Management Market: Overview The market for wound care is growing phenomenally, due to growing advancement is treating complex wounds. Advanced wound care market is anticipated to grow ...

Animal Wound Care Market by Product Animal & End User - Global Forecast to 2021

Animal Wound Care Market by Product Animal & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global animal wound care market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 1,134.0 million by 2021 from USD 818.8 million in 2016. The growth of this market is mainly attributed ...

Burn Care Market by Product, Biologics, Traditional), Depth, End-Users, Physician Clinics, Homecare - Forecast to 2021

Burn Care Market by Product, Biologics, Traditional), Depth, End-Users, Physician Clinics, Homecare - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The burn care market is expected to reach USD 2.33 billion by 2021 from USD 1.68 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. Market growth can be attributed to factors such as rising incidence ...

Global Advanced Wound Care Industry

September 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.